AMGN vs MRNA · P/E 24, rev $10.05B vs rev $145.0M
Amgen Inc (AMGN) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the AMGN and MRNA stock pages for the full models.
Not investment advice.